The medical industry is seeing a significant shift in diabetes therapy with the emergence of GLP-1 skin applications. These revolutionary vehicles offer a possibly convenient alternative to subcutaneous injections for individuals managing type 2 diabetes. By circumventing the necessity for frequent injections, GLP-1 patches promise to improve user